CME Information

The Annual Meeting will provide continuing medical credits based on attendees’ participation in the activity. Attendees can claim credit by completing the evaluations for the sessions attended via a survey sent following the event. Completion of session and global evaluations is required, and evaluations may be submitted only once. Therefore, attendees should not begin evaluations until they have completed participation in the certified content for which they wish to claim credit.

The deadline to claim CME and MOC credit is December 3, 2024 by 11:59 ET.

Program Objectives

The 2024 Annual Meeting of the American Thyroid Association aims to:

  • Provide a professional forum to discuss and apply the most recent knowledge pertaining to basic science and translational research appropriate for basic scientists and clinicians that care for issues related to thyroid.
  •  Differentiate the changes in guidelines and highlight best practices for adoption into clinical practice.
  •  Identify new and clinically relevant evidence-based management and treatment(s), using the most up-to-date clinical and scientific information.

Continuing Medical Education Credit Information

Accreditation

The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American Thyroid Association designates this live activity for a maximum of 26.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

General & Plenary Sessions are a total of 20 AMA PRA Category 1 Credits™

American Internal Medicine Board (ABIM) & Amercian Board of Otolaryngology – Head Neck and Surgery (ABOHNS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 26.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and Amercian Board of Otolaryngology – Head Neck and Surgery (ABOHNS) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

American Board of Surgery Continuous Certification

The American Board of Surgery

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

To submit credit on the learner’s behalf, ATA must have the learner’s date of birth on file.

Commercial Support

The American Thyroid Association acknowledges RGS Healthcare and Esaote for their in-kind support of this educational activity by providing ultrasound machines for the ultrasound workshop(s).

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months. Please note that first authors were required to collect and submit disclosure information on behalf of all other authors/contributors, if applicable.

The ACCME also requires that ATA manage any reported relevant financial relationships and eliminate the potential for bias during the educational activity. Any relevant financial relationships noted have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. Any person not listed below did not have any relevant financial relationship(s).

Name of Individual Individual’s Role(s) in Activity
(e.g. Planner, Reviewer, Speaker, Author, Moderator, Panelist)
Name of Ineligible Company(s) Nature of Relevant Financial Relationship(s)
Ali Alzahrani Faculty APSEN
Newbridge
Amgen
Speaker (ended 02/2024);
Advisor;
Advisor
Andrew J Bauer Faculty Egetis Pharmaceuticals; IBSA Consultant
Antonio C. Bianco Faculty Abbvie, Acella, Aligos, Synthonics Consultant
Benjamin Gigliotti Moderator Amgen (ended 7/24), Immunovant (ended 10/23) Advisory Board
Bhavana Konda Faculty Eisai; Merck; Xencor (ended) Research Funding
Bryan R Haugen Faculty Eisai (ended);
Veracyte
Consultant;
Researcher
Carla Moran Faculty Egetis Advisor
Cary N Mariash Planner; Moderator Horizon Therapeutics (Amgen) Consultant
Catherine A. Dinauer Moderator IBSA Research Funding
Chrysoula Dosiou Faculty Sling
Immunovant
Horizon (ended 09/23)
Septerna (ended 06/24)
Third Rock
The Column Group (ended 05/23)
Advisor
Consultant
Consultant
Consultant
Consultant
Consultant
Elizabeth Grubbs Faculty Eli Lilly; Exelixis Research Funding
Elizabeth N. Pearce Faculty Merck China Speaker
F. Thurston Drake Faculty Pfizer;
Corcept Therapeutics;
Speaker;
Individual Stocks
Ferdy van Geest Faculty Egetis Therapeutics AB Consultant
George J. Kahaly Faculty Immunovant Researcher; Consultant
Jennifer Hong Kuo Moderator Medtronic Consultant
Johnson Thomas Moderator AIBx (ended 7/24) Ownership Interest
Jonathon Russell Faculty Baxter Scientific (ended 9/24) Consultant
Josef Köhrle Faculty DiaSorin Deutschland GmbH (ended 2/23); IBSA Corporate (ended 1/24) Speaker
Julie Ann Sosa Faculty; Moderator Exelixis; Eli Lilly; Lilly
Novo Nordisk; Astra Zeneca; Eli Lilly
Research Funding;
Consultant
Julien Hadoux Faculty Lilly; Bayer; Eisai; Sanofi; IPSEN; Roche (ended 5/22)
ITM (ended 3/22); HRA Pharma (ended 02/24)
Advisor
Speaker
Kristien Boelaert, Planner Lilly, Serb(ended), Egetis Theraputics (ended) Advisor
Laura Ryan Faculty Amgen Speaker
Leonidas Duntas Moderator Merck (ended), Berline Chemie Speaker
Maisie Shindo Faculty Mender Consultant
Marcia S Brose Moderator; Faculty Bayer; Eusau; Ekkuosus; Exelixis; Aadi;Ipsen; Lilly Consultant
Marco Medici Moderator ACE Pharmaceuticals Research Funding
Maria Cabanillas Faculty Novartis;
Merck;
Exelixis (ended 09/23);
Bayer (ended 9/22)
Consultant
research Funding
Advisor
Consultant
Marina N. Nikiforova Planner Sonic Healthcare, USA
University of Pittsburg
Consultant
IP ownership & royalties related to ThyroSeq
Marius Stan Faculty Amgen, ArgenX, Avilar, Genentech, Immunovant, Lassen, Lundbeck, MingHiu Pharma, Septerna, Third Rock Vnetures, Tourmaline, Tshaka Inc, Viridian, Grofols (ended 5/24) Consultant
Mark Zafereo Faculty Eli Lilly;
Merck;
Exelixis
Researcher
Maya Lodish Planner Institut Biochimigque;
Eli Lilly;
Neurocrine;
Recordati
Researcher;
Researcher;
Consultant;
Researcher
Mayumi Endo Moderator Bayer (ended 12/23);
Abbvie (ended 12/23)
Consultant
Melanie Goldfarb Planner; Moderator Starmed Speaker
Melinda Pierce Faculty Rhythm Pharmaceuticals (ended 10/23) Advisor
Mimi Hu Faculty Eli Lilly Research Funding
Nancy Reau Faculty Salix;
VIR;
Gilead;
Arbutus;
AbbVie (ended 7/24)
Researcher, Consultant;
Consultant;
Researcher, Consultant;
Consultant
Researcher
Nicole Massoll Faculty Interpace Diagnostics Consultant
Nikita Pozdeyev Faculty Veracyte Research Funding
Ralf Paschke Faculty Alberta Precision Laboratories Royalties
Robert Michael Tuttle Faculty Elesta (ended 8/24) Researcher
Robert Sargis Faculty CVS Health Advisor
Roopa Kanakatti-Shankar Faculty BioMarin researcher
Rossella Elisei Faculty Eisai; Ipsen; Lilly; Bayer; Roche Consultant
Rossella Elisei Faculty Eisai; Ipsen; Lilly; Bayer; Roche Consultant
Russell Smith Faculty Mendaera (ended 4/23) Consultant
Sara Ahmadi Planner; Faculty Veracyte Research Funding
Sean Wrenn Faculty StarMedUSA (ended 8/10/24) Advisor
Shoaib Ugradar Faculty Amgen Consultant
Sofie Bliddal Moderator Extempore Speaker
Steven I Sherman Faculty Novartis (Ended 8/31/2023); Bayer (Ended 3/19/2024; Eli Lilly (Ended 9/11/2024)
Eli Lilly
Consultant;
Research Funding
Steven Waguespack Faculty Bayer Consultant
Suzanne K Freitag Faculty Horizon, Viridian, Sling, Medtronic, Immunovant, Janssen, Kriya, WL Gore, Lassen, Poriferous, Third Rock/ASPEN Consultant
Thomas Scanlan Moderator; Faculty Autobahn Therapeutics Consultant
Tim Korevaar Faculty Berlin Chemie (ended 12/23);
IBSA (ended 01/24);
Merck (ended 05/24)
Speaker
Tim Korevaar Faculty Merk (ended 5/24); Berlin Chemie (ended 12/23); ISBA (ended 01/24) Speaker
Tracy Tylee Moderator AbbVie, Monod Bio Advisor
Victoria Banuchi Faculty Medtronic (ended 2/24) Consultant
Zoltan Antal Planner; Faculty Bayer Consultant
Francis Worden Faculty Eisai;
Merck;
Bayer;
Exelexis
Advisory Board/Consulting;
Advisory Board;
Advisory Board;
Exelexis
Elizabeth McAninch Faculty Acella Pharmaceuticals Consultant